Entheon Biomedical
Business Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
595 Howe St Fl 10, Vancouver, British Co...Phone Number
(604) 562-3932Website
www.entheonbiomedical.comRevenue
$5.3 MillionStock Symbol
ENTBFIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Entheon Biomedical
Entheon Biomedical Corp. is focused on developing innovative solutions in the field of biomedical technology. The company aims to provide advanced products and services that cater to the needs of healthcare professionals and patients. Their intended clients include medical institutions and practitioners seeking cutting-edge biomedical applications. With a commitment to enhancing health outcomes, Entheon is poised to make significant contributions to the biomedical industry.Explore more
Entheon Biomedical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Entheon Biomedical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Entheon Biomedical is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Entheon Biomedical
Entheon Biomedical, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Entheon Biomedical has new funding data
Product Launch: Get notified when Entheon Biomedical launches new products
Click to see if Entheon Biomedical had a recent Job posting/layoffs
Check if Entheon Biomedical has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Entheon Biomedical recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Entheon Biomedical
Find more new buyers
Compare Similar Companies to Entheon Biomedical
Compare insights from companies similar to Entheon Biomedical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Entheon Biomedical is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Entheon Biomedical is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Entheon Biomedical.
Entheon Biomedical Tech Stack
A closer look at the technologies used by Entheon Biomedical
Entheon Biomedical News & Media
Entheon Appoints Successful Cannabis Founder to Board of Directors | ENTBF Stock News
Fire & Flower co-founder Harrison Newlands brings cannabis expertise and successful track record in scaling startups to strengthen Entheon's leadership. Full analysis inside.Entheon Announces Closing of Previously Announced Sale of Certain DMT Clinical Assets
Vancouver, British Columbia--(Newsfile Corp. - July 11, 2022) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("Entheon" or the "Company") today announced that, further to its news release dated June 7, 2022, it has completed the sale of its Phase 1 N,N-dimethyltryptamine ("DMT") study (the "DMT Study") to Cybin IRL Limited (the "Purchaser"), a subsidiary of Cybin Inc. pursuant to an asset purchase agreement for a purchase price of CAD$1,000,000 (the "Transaction"). In...Largest Phase-1 DMT Study In The Netherlands, A Collaboration Between Entheon & Cybin
Cybin Inc. (NEO:CYBN) (NYSE American: CYBE) announced that, through its wholly-owned subsidiary Cybin IRL Limited, It has entered into an agreement to acquire a Phase 1 N,N-dimethyltryptamine (“DMT”) study from Entheon Biomedical Corp. read moreEntheon Announces Sale of Certain DMT Clinical Assets and Filing of Provisional Novel Compound Patents
Vancouver, British Columbia--(Newsfile Corp. - June 7, 2022) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("Entheon" or the "Company") today announced that it has entered into a definitive agreement (the "Agreement") dated June 7, 2022 with Cybin IRL Limited (the "Purchaser"), a subsidiary of Cybin Inc. ("Cybin"), pursuant to which the Company has agreed to sell its Phase 1 N,N-dimethyltryptamine ("DMT") study (the "DMT Study") to the Purchaser (the "Transaction") for a...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Entheon Biomedical
Sign Up For FreeTo access detailed company insights
Entheon Biomedical Corp. is focused on developing innovative solutions in the field of biomedical technology. The company aims to provide advanced products and services that cater to the needs of healthcare professionals and patients. Their intended clients include medical institutions and practitioners seeking cutting-edge biomedical applications.... Read More
